Patheon completes York Mills facility sale
The agreement to sell the facility for a purchase price of CDN$12.5 million (US$12.3 million) was entered into on December 31, 2007 as part of Patheon's global network restructuring plan. Patheon is currently in the process of transferring all commercial production and development services undertaken at its York Mills facility to, primarily, its Whitby facility, with a smaller portion of activity being transferred to the Company's Mississauga and Cincinnati facilities. This is primarily intended to improve capacity utilization and profitability at the continuing Canadian sites.
Patheon is de-commissioning the York Mills facility and has leased back the facility for up to two years in order to facilitate this process.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.